Non hodgkin lymphoma represent phatology in men in fertile age and includes about 8% of all cancer diagnosis in men aver 15-45 years. In recent years overall survival of these patients has improved remarkably. Thus, new challenges regarding reproductive outcome have emerged as many antineoplastic regimens utilised as chemotherapy (CH) and radiotherapy (RT), stem cell transplantation (SCT), are known to alter semen quality
Semen quality and fertility before and after therapy in patients affected by non Hodgkin Lymphoma
Pallotti Francesco;
2018-01-01
Abstract
Non hodgkin lymphoma represent phatology in men in fertile age and includes about 8% of all cancer diagnosis in men aver 15-45 years. In recent years overall survival of these patients has improved remarkably. Thus, new challenges regarding reproductive outcome have emerged as many antineoplastic regimens utilised as chemotherapy (CH) and radiotherapy (RT), stem cell transplantation (SCT), are known to alter semen qualityFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
